Linked Life Data

20036895

Source:http://linkedlifedata.com/resource/pubmed/id/20036895

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-12-28
pubmed:abstractText
This review describes genetic and molecular changes related to adenocarcinoma of the esophagus and gastroesophageal junction (GEJ) with emphasis on prognostic value and possibilities for targeted therapy in clinical setting. The progression of Barrett's esophagus to adenocarcinoma has been the focus of particular scrutiny, and a number of potential tissue and serum-based disease biomarkers have emerged. Tissue biomarkers allowing risk stratification of Barrett's are reviewed as well as strategies currently being used to discover novel biomarkers that will facilitate the early detection of esophageal adenocarcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1945-0508
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
489-94
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Clinical biomarkers in esophageal adenocarcinoma.
pubmed:affiliation
Section of General Surgery and Oncology, Department of General Surgery, University Medical School of Catania, Catania, Italy. biondian@tin.it
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't